SEVERANCE AGREEMENTSeverance Agreement • July 23rd, 2018 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledJuly 23rd, 2018 Company Industry JurisdictionThis Severance Agreement (the “Agreement”) is entered into as of July 18, 2018 (the “Effective Date”) by and between Anthony Quinn (the “Executive”) and Aeglea BioTherapeutics, Inc., a Delaware corporation (the “Company”).